Mosaic ImmunoEngineering, Inc.
CPMV
$0.897
$0.39980.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -37.83% | -21.09% | -40.65% | -35.30% | -7.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.72% | -34.97% | -45.50% | -40.24% | -22.18% |
| Operating Income | 45.72% | 34.97% | 45.50% | 40.24% | 22.18% |
| Income Before Tax | 42.25% | 37.16% | 49.05% | 43.97% | -1,598.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 41.44% | 37.16% | 48.24% | 43.97% | -1,598.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.44% | 37.16% | 48.24% | 43.97% | -1,598.47% |
| EBIT | 45.72% | 34.97% | 45.50% | 40.24% | 22.18% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 41.38% | 37.09% | 48.28% | 44.03% | -1,603.70% |
| Normalized Basic EPS | 42.13% | 36.69% | 48.82% | 43.51% | 11.81% |
| EPS Diluted | 41.38% | 37.09% | 48.28% | 40.00% | -1,865.22% |
| Normalized Diluted EPS | 42.13% | 36.69% | 48.82% | 43.51% | -4.53% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -15.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |